Annual Long Term Debt
$255.00 K
-$450.00 K-63.83%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual long term debt is $255.00 thousand, with the most recent change of -$450.00 thousand (-63.83%) on December 31, 2023.
- During the last 3 years, AVTE annual long term debt has risen by +$255.00 thousand (+100.00%).
- AVTE annual long term debt is now -89.80% below its all-time high of $2.50 million, reached on December 31, 2019.
Performance
AVTE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$81.00 K
-$125.00 K-60.68%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly long term debt is $81.00 thousand, with the most recent change of -$125.00 thousand (-60.68%) on September 30, 2024.
- Over the past year, AVTE quarterly long term debt has dropped by -$174.00 thousand (-68.24%).
- AVTE quarterly long term debt is now -90.60% below its all-time high of $862.00 thousand, reached on June 30, 2022.
Performance
AVTE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AVTE Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -63.8% | -68.2% |
3 y3 years | +100.0% | -68.2% |
5 y5 years | -89.8% | -68.2% |
AVTE Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -63.8% | at low | -90.6% | at low |
5 y | 5-year | -89.8% | -100.0% | -90.6% | -100.0% |
alltime | all time | -89.8% | -100.0% | -90.6% | -100.0% |
Aerovate Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $81.00 K(-60.7%) |
Jun 2024 | - | $206.00 K(-37.4%) |
Mar 2024 | - | $329.00 K(+29.0%) |
Dec 2023 | $255.00 K(-63.8%) | $255.00 K(-28.8%) |
Sep 2023 | - | $358.00 K(-24.8%) |
Jun 2023 | - | $476.00 K(-19.5%) |
Mar 2023 | - | $591.00 K(-16.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $705.00 K(+84.6%) | $705.00 K(-11.9%) |
Sep 2022 | - | $800.00 K(-7.2%) |
Jun 2022 | - | $862.00 K(+157.3%) |
Mar 2022 | - | $335.00 K(-12.3%) |
Dec 2021 | $382.00 K(>+9900.0%) | $382.00 K(-15.5%) |
Sep 2021 | - | $452.00 K(>+9900.0%) |
Dec 2020 | $0.00(-100.0%) | $0.00 |
Dec 2019 | $2.50 M | - |
FAQ
- What is Aerovate Therapeutics annual long term debt?
- What is the all time high annual long term debt for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual long term debt year-on-year change?
- What is Aerovate Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly long term debt year-on-year change?
What is Aerovate Therapeutics annual long term debt?
The current annual long term debt of AVTE is $255.00 K
What is the all time high annual long term debt for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual long term debt is $2.50 M
What is Aerovate Therapeutics annual long term debt year-on-year change?
Over the past year, AVTE annual long term debt has changed by -$450.00 K (-63.83%)
What is Aerovate Therapeutics quarterly long term debt?
The current quarterly long term debt of AVTE is $81.00 K
What is the all time high quarterly long term debt for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly long term debt is $862.00 K
What is Aerovate Therapeutics quarterly long term debt year-on-year change?
Over the past year, AVTE quarterly long term debt has changed by -$174.00 K (-68.24%)